Duavive (2020-05-20)

Starting date:
May 20, 2020
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-73183

Last updated:

Summary

  • Product: Duavive Tablet

Reason

The affected lots may not meet the specification for dissolution of bazedoxifene during the product shelf-life.

Depth of distribution

Wholesalers, Retailers

Affected products

Duavive Tablet

DIN, NPN, DIN-HIM

DIN 02432854

Dosage form

Tablet (Immediate And Extended Release)

Strength

Bazedoxifene 20 mg
Conjugated Estrogens 0.45 mg

Lot or serial number

AH6679, X51932, DC8998, AN0290

Companies

Recalling Firm
Pfizer Canada Inc.
17300 Trans-Canada Hwy.
Kirkland
H9J 2M5
Ontario
CANADA
Marketing Authorization Holder
Pfizer Canada Inc.
17300 Trans-Canada Hwy.
Kirkland
H9J 2M5
Ontario
CANADA